Company intelligence / Profile preview

Douyin

Beijing, Beijing, Chinadouyin.com ↗
Ownership
Private
Development stage
Other
01

Overview

Douyin is a leading short-video social media platform in China, owned and operated by ByteDance. While primarily a technology and entertainment entity, it has become a significant channel for healthcare information, medical education, and telemedicine marketing. The platform facilitates interactions between healthcare professionals and the public, hosting a vast array of health-related content. Its parent company, ByteDance, has further expanded into the healthcare sector through the acquisition of hospital groups and the development of the Xiaohe Health platform. Douyin itself does not engage in traditional biotechnology research, drug discovery, or clinical development.

Industry
Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Douyin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Douyin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call